Related references
Note: Only part of the references are listed.Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study
Laure Dossus et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma 2018 Update
Barbara Jarzab et al.
ENDOKRYNOLOGIA POLSKA (2018)
The association between thyroid cancer and insulin resistance, metabolic syndrome and its components: A systematic review and meta-analysis
De-tao Yin et al.
INTERNATIONAL JOURNAL OF SURGERY (2018)
Prognostic significance of serum chemerin levels in patients with non-small cell lung cancer
Chun-Hua Xu et al.
ONCOTARGET (2017)
Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?
Roberta Malaguarnera et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Serum 25-Hydroxyvitamin D Level Does Not Affect the Aggressiveness and Prognosis of Papillary Thyroid Cancer
Hwa Young Ahn et al.
THYROID (2016)
Evolving role of adiponectin in cancer-controversies and update
Arnav Katira et al.
CANCER BIOLOGY & MEDICINE (2016)
Significance of Interleukin-6 in Papillary Thyroid Carcinoma
Toral P. Kobawala et al.
JOURNAL OF THYROID RESEARCH (2016)
Adiposity and risk of thyroid cancer: a systematic review and meta-analysis
D. Schmid et al.
OBESITY REVIEWS (2015)
Imaging, genetic testing, and biomarker assessment of follicular cell-derived thyroid cancer
Hetal H. Patel et al.
ANNALS OF MEDICINE (2014)
Increased serum chemerin level promotes cellular invasiveness in gastric cancer: A clinical and experimental study
Chunhu Wang et al.
PEPTIDES (2014)
Circulating Adipokines in Healthy versus Unhealthy Overweight and Obese Subjects
Assim A. Alfadda
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Mechanisms Inking excess adiposity and carcinogenesis promotion
Ana I. Perez-Hernandez et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Plasma Levels of Adiponectin and Primary Liver Cancer Risk in Middle-Aged Japanese Adults with Hepatitis Virus Infection: A Nested Case-Control Study
Takehiro Michikawa et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer
Hye Jeong Kim et al.
CLINICAL ENDOCRINOLOGY (2013)
Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population
Ji Min Han et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Metformin Inhibits Growth of Thyroid Carcinoma Cells, Suppresses Self-Renewal of Derived Cancer Stem Cells, and Potentiates the Effect of Chemotherapeutic Agents
Guofang Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can)
Martin Almquist et al.
CANCER CAUSES & CONTROL (2011)
Diabetes and Thyroid Cancer Risk in the National Institutes of Health-AARP Diet and Health Study
Briseis Aschebrook-Kilfoy et al.
THYROID (2011)
Leptin: A Correlated Peptide to Papillary Thyroid Carcinoma?
Mehdi Hedayati et al.
JOURNAL OF THYROID RESEARCH (2011)
Cytokines, thyroid diseases and thyroid cancer
Franco Lumachi et al.
CYTOKINE (2010)
Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma
Shahab Uddin et al.
ENDOCRINE-RELATED CANCER (2010)
Rising thyroid cancer incidence in the world might be related to insulin resistance
Alptekin Gursoy
MEDICAL HYPOTHESES (2010)
Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study
Maria Dalamaga et al.
CANCER CAUSES & CONTROL (2009)
Share Paper
